Kai Xu
- Molecular Biology
- Pollution top 5%
- Cancer Research top 10%
- Immunology
- Plant Science
- Topics
- Epigenetics and DNA Methylation (6 papers)Cancer Immunotherapy and Biomarkers (5 papers)RNA modifications and cancer (5 papers)
- Partner nations
- ChinaBangladeshUnited States
In The Last Decade
Kai Xu
72 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 121
- Molecular Biology 406
- Pollution 234
- Cancer Research 172
- Immunology 171
- Plant Science 125
Countries citing papers authored by Kai Xu
This map shows the geographic impact of Kai Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kai Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kai Xu more than expected).
Fields of papers citing papers by Kai Xu
This network shows the impact of papers produced by Kai Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kai Xu. The network helps show where Kai Xu may publish in the future.
Co-authorship network of co-authors of Kai Xu
This figure shows the co-authorship network connecting the top 25 collaborators of Kai Xu. A scholar is included among the top collaborators of Kai Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kai Xu. Kai Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 2 | |
| 3 | 1 | |
| 4 | 1 | |
| 5 | 3 | |
| 6 | 1 | |
| 7 | 46 | |
| 8 | 14 | |
| 9 | 3 | |
| 10 | 7 | |
| 11 | 33 | |
| 12 | Correlations of breast cancer FHIT gene with the incidence and prognosis of breast cancer. | 3 |
| 13 | 53 | |
| 14 | 25 | |
| 15 | 33 | |
| 16 | Research Progress in Pharmacologic Action and Mechanism of Ginseng Radix et Rhizoma Extract for Treating Alzheimer's Disease | 1 |
| 17 | Therapeutic Observation on Electroacupuncture for Cervical Vertigo | 2 |
| 18 | Observations on the Efficacy of Thunder-fire Moxibustion in Treating Gastralgia of Deficiency Cold Type | 1 |
| 19 | EUS-guided oncolytic adenovirus implantation in patients of non-operative pancreatic cancer | 1 |
| 20 | Radiotherapy combined with concomitant chemotherapy for stage III non-small cell lung cancer | 1 |
About Kai Xu
Kai Xu is a scholar working on Cancer Research, Geriatrics and Gerontology and Complementary and alternative medicine, having authored 75 papers that have together received 1.3k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (6 papers), Cancer Immunotherapy and Biomarkers (5 papers) and RNA modifications and cancer (5 papers). The work is most often cited by research in Pollution (234 citations), Neurology (118 citations) and Industrial and Manufacturing Engineering (103 citations). Kai Xu has collaborated with scholars based in China, Bangladesh and United States. Frequent co-authors include Rongli Sun, Yuepu Pu, Juan Zhang, Yunqiu Pu, Lihong Yin, Jiawei Huang, Fei Xiong, Jinyan Liu, Manman Liu and Fujian Ni. Their work appears in journals such as Journal of Biological Chemistry, Circulation Research and The Science of The Total Environment.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.